skip to main content
Refinado por: assunto: Humans remover assunto: Pharmacokinetics remover Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults
Material Type:
Artigo
Adicionar ao Meu Espaço

Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults

Landry, Ishani ; Nakai, Kenya ; Ferry, Jim ; Aluri, Jagadeesh ; Hall, Nancy ; Lalovic, Bojan ; Moline, Margaret L.

Clinical pharmacology in drug development, 2021-02, Vol.10 (2), p.153-165 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

2
Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors
Material Type:
Artigo
Adicionar ao Meu Espaço

Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors

Shapiro, Geoffrey I. ; Kristeleit, Rebecca S. ; Burris, Howard A. ; LoRusso, Patricia ; Patel, Manish R. ; Drew, Yvette ; Giordano, Heidi ; Maloney, Lara ; Watkins, Simon ; Goble, Sandra ; Jaw‐Tsai, Sarah ; Xiao, Jim J.

Clinical pharmacology in drug development, 2019-01, Vol.8 (1), p.107-118 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

3
Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials
Material Type:
Artigo
Adicionar ao Meu Espaço

Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials

Devarakonda, Krishna ; Kostenbader, Kenneth ; Giuliani, Michael J ; Young, Jim L

BMC pharmacology & toxicology, 2015-11, Vol.16 (1), p.31, Article 31 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

4
Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant

Landry, Ishani ; Aluri, Jagadeesh ; Hall, Nancy ; Kumar, Dinesh ; Dayal, Satish ; Moline, Margaret ; Reyderman, Larisa

Pharmacology research & perspectives, 2020-12, Vol.8 (6), p.e00678-n/a [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

5
Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant

Dayal, Satish ; Aluri, Jagadeesh ; Hall, Nancy ; Filippov, Gleb ; Moline, Margaret ; Reyderman, Larisa ; Landry, Ishani

Pharmacology research & perspectives, 2021-04, Vol.9 (2), p.e00758-n/a [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

6
Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant

Landry, Ishani ; Aluri, Jagadeesh ; Hall, Nancy ; Filippov, Gleb ; Dayal, Satish ; Moline, Margaret ; Reyderman, Larisa

Pharmacology research & perspectives, 2021-04, Vol.9 (2), p.e00734-n/a [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.